Breast Cancer - Navigate - Prospective Cohort

Launched by NORTHWESTERN UNIVERSITY · Feb 14, 2024

Keywords

ClinConnect Summary

The Breast Cancer Navigate trial is studying how a new online platform, called BC-Navigate, can help women of color who are diagnosed with breast cancer. This program aims to support these women in understanding their treatment options and advocating for themselves during their care. The goal is to ensure that they start their chemotherapy treatments on time and to see if this digital support makes a positive difference in their experience and quality of life.

To be eligible for this study, participants must be at least 18 years old, have been diagnosed with early-stage breast cancer (stages I-III), and have not yet started their chemotherapy after surgery. They should be receiving care at Northwestern Medicine and have access to the internet on a smartphone or computer. Women from any ethnic background can participate, but men are excluded from this trial. If you join, you will receive guidance through the BC-Navigate platform, which offers helpful resources and support as you go through your treatment journey.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • 18 years of age and older
• • Diagnosed with non-metastatic breast cancer (stages I-III)
• • An order placed for a post-operative chemotherapy cycle by a NM clinician
• • Not have initiated a recommended post-operative chemotherapy cycle at the time of study enrollment
• • Completed surgery for breast cancer
• • First-time diagnosis of breast cancer
• • Established care at Northwestern Medicine
• • English-speaking as the navigation website is not yet available in other languages
• • Access to internet on a smart phone or computer/tablet
• • Any ethnic background
• • We will only consider patients that sign an informed consent form
• Exclusion Criteria:
• • Men will be excluded because the navigation website only contains content and resources for women. Men also make up less than 1% of all breast cancer diagnoses and the Breast Cancer-Navigate app/website content was developed for female breast cancer patients.
• • Diagnosis of additional, life-threatening condition (e.g., end-stage renal disease, heart failure) which can interfere with timely planned adjuvant chemotherapy treatment for cancer.